Envigo

Envigo is a provider of non-clinical research and development and regulatory consulting services to pharmaceutical and chemical industries. Read more

Adrian Hardy's photo - President & CEO of Envigo

President & CEO

Adrian Hardy

CEO Approval Rating

89/100

Founded:

2015

Status:

ENVIGO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Charles River is a top competitor of Envigo. Charles River was founded in 1947, and is headquartered in Wilmington, Massachusetts. Like Envigo, Charles River also competes in the Medical Research & Laboratories field. Charles River generates $2.5B more revenue vs. Envigo.

LabCorp is seen as one of Envigo's top competitors. LabCorp is headquartered in Burlington, North Carolina, and was founded in 1905. Like Envigo, LabCorp also operates in the Medical Research & Laboratories field. LabCorp generates 3,063% the revenue of Envigo.

Eurofins has been one of Envigo's top competitors. Eurofins's headquarters is in Luxembourg, Luxembourg, and was founded in 1987. Eurofins is in the Biotechnology industry. Eurofins generates 1,336% of Envigo's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is SGS a competitor of Envigo?

Envigo Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Animal Research Models Business, Horizon Discovery Group plc

Nov 2019

Source »
undisclosed
-

These are all the companies that Envigo has acquired. Envigo's latest acquisition was Animal Research Models Business, Horizon Discovery Group plc in Nov 2019.

Envigo Funding History

No recent funding data found related to Envigo

Envigo Investments

No recent investments found related to Envigo

These are all the companies that Envigo has invested in. Envigo's latest investment was Animal Research Models Business, Horizon Discovery Group plc in Nov 2019.

Envigo News

June 5, 2019Pharmabiz

LabCorp completes acquisition of Envigo's global nonclinical contract research business

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, an... See more »
April 23, 2019BioPortfolio

LabCorp Envigo deal will see both companies focus and expand respective expertise

LabCorps Covance Drug Development segment is set to acquire Envigos nonclinical research services bus... See more »
April 20, 2019Pharmabiz

LabCorp, Envigo ink agreement to expand nonclinical drug development capabilities

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, an... See more »
April 18, 2019WRAL TechWire

Hundreds of employees to swap companies in complex $485M LabCorp deal

Hundreds of employees will be swapping companies as part of a $485 million deal life science giant La... See more »
March 12, 2019Contract Pharma

Envigo Launches PATHWAY

Designed to optimize non-clinical safety assessment programs... See more »
March 11, 2019Applied Clinical Trials

Envigo launches PATHWAY

Envigo, a provider of non-clinical contract research services and research models, announced PATHWAY ... See more »
March 11, 2019Outsourcing-Pharma

Envigo paves new first-in-human trial solution

The non-clinical contract research services and research model provider Envigo launches a new solutio... See more »

Envigo Blogs

October 14, 2020Envigo Blog

Progress in diets to induce nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing, with ~24% of the US and Eur... See more »
September 14, 2020Envigo Blog

Patient-derived xenograft: making personalized medicine even more personal

It is well established that personalized medicine can overcome some limitations of a one-size-fits-al... See more »
August 4, 2020Envigo Blog

Cryopreservation and rederivation: Two steps forward, no setback

Effective colony management ensures reproducible research outcomes and adherence to the principles of... See more »
June 17, 2020Envigo Blog

How COVID-19 has changed the biomedical industry

The shift in research priorities due to COVID-19 has required rapid adjustment across the biomedical ... See more »
May 18, 2020Envigo Blog

4 tips to help secure research funding

Securing research funding is becoming increasingly difficult with the ever-growing competition across... See more »
April 21, 2020Envigo Blog

Rodents in research: is 2020 the year of the lab rat?

Lab rats and mice have been used for decades to make great medical advances, from HIV antiretrov... See more »
March 9, 2020Envigo Blog

Care and husbandry for immunodeficient rodents: guidance to reduce risks in your research

Immunodeficient rodents can serve as a valuable part of basic research studies to help researchers be... See more »

Envigo Press Releases

July 31, 2017Blackbird

Global Chikungunya Fever Market Provides a Snapshot of the Global Clinical Trials Landscape

Orbis Research has announced the addition of the "Chikungunya Fever Global Clinical Trials Review, H1... See more »
March 6, 2017Business Wire

Mice Model Market to Reach $1.59 Billion in 2021 - Personalized Medicine Driving the Demand for Humanized Mice Models - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Mice Model Market - ... See more »
November 1, 2016Thailand Press Release News

Envigo Holdings Inc. Assigned #B-# Corporate Credit Outlook Debt Ratings Assigned

NEW YORK (SP Global Ratings) Oct. 31, 2016-SP Global Ratings said today that it assigned its #B-# cor... See more »
October 24, 2016NewsMaker

Mice Model Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2021 in Japan

Mice Model Market is expected to witness growth of international market with respect to advancements ... See more »
August 10, 2016NewsMaker

Animal Genetics Industry Overview, Growth, Demand and Trends Analysis 2016

This report studies Animal Genetics in Global market, especially in North America, Europe, China, Jap... See more »
March 2, 2016Business Wire

Mice Models Are Indispensable Tools in Research Activities With their Capability to Elucidate Human Disease Processes - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v782dr/knoc... See more »

Envigo Videos

Social Media

Envigo Headquarters

8520 Allison Pointe Boulevard Suite 400

Indianapolis, Indiana46250

1-800-793-7287

Driving Directions »

Trending Companies

Envigo Summary

ABOUT

Overview

Envigo is a provider of non-clinical research and development and regulatory consulting services to pharmaceutical and chemical industries. Envigo was founded in 2015. Envigo's headquarters is located in Indianapolis, Indiana, USA 46250. Envigo's late...

CEO

Envigo's President & CEO, Adrian Hardy, currently has an approval rating of 89%. Envigo's primary competitors are Charles River, LabCorp & Eurofins.

Website

envigo.com

Frequently Asked Questions about Envigo

  1. When was Envigo founded?

    Envigo was founded in 2015
  2. Who is Envigo's CEO?

    Envigo's CEO is Adrian Hardy
  3. How much revenue does Envigo generate?

    Envigo generates $500M in revenue
  4. How much funding does Envigo have?

    Envigo has historically raised $0 in funding
  1. Where is Envigo's headquarters?

    Envigo's headquarters is in Indianapolis Indiana, USA
  2. How many employees does Envigo have?

    Envigo has 1,200 employees
  3. What sector does Envigo operate in?

    Envigo is in Pharmaceuticals, Medical Research & Laboratories
  4. Who are Envigo's competitors?

    Envigo's top competitors are Charles River, LabCorp, Eurofins